FDA Enforcement Class II Terminated

Aesculap GNI161 Bipolar Foot Control Product Usage: The Aesculap Bipolar Coagulator is intended for use in surgery to generate electrical power for bipolar instruments. Bipolar coagulators are used in neurosurgery, ENT surgery, urology, laparoscopy, and plastic surgery.

Recall: Z-0479-2014 · Reported December 18, 2013

Enforcement

Recall Number
Z-0479-2014
Event ID
66533
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Aesculap, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 18, 2013
Initiation Date
September 10, 2013
Classification Date
December 10, 2013
Termination Date
October 20, 2014
Address
3773 Corporate Pkwy, Center Valley, PA, 18034-8217, United States

Description

Aesculap GNI161 Bipolar Foot Control Product Usage: The Aesculap Bipolar Coagulator is intended for use in surgery to generate electrical power for bipolar instruments. Bipolar coagulators are used in neurosurgery, ENT surgery, urology, laparoscopy, and plastic surgery.

Reason

Complaints were received for the GN161 Bipolar Foot Control reporting that the bipolar energy did not stop after release of the foot control.

Code Info

all GN161's distributed between 4/28/2009 and 5/22/2013.

Distribution

Worldwide Distribution - USA Nationwide and countries of: Austria, Germany, Japan, and Taiwan.

Quantity

85